ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For The Month of July

July 27, 2012

713 Nurses Pass Certification exam At ONS Congress

July 8, 1988

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

In Brief: House Fills Subcommittee Positions; Senate Schedules NCI Appropriations Hearing Feb. 18

February 13, 1981

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003